Of all patients who made it past week 12 without stopping treatment, 87% went on to lose at least 15% of their total body weight by week 48
However, with rapid results can come an unexpected side effect: the Ozempic facea term used to describe the hollowed, sagging appearance that some patients experience as their facial fat rapidly disappears
Yes, if you meet NICE eligibility criteria, typically when triple oral therapy for type 2 diabetes is inadequate and specific BMI or comorbidity thresholds apply
Observational studies and some ophthalmology commentaries have been more reassuring overall, suggesting that many patients taking semaglutide do not experience clinically meaningful retinal worsening
It is in the midst of awaiting federal approval for its once-daily oral obesity drug Orforglipron
Bonuses are best viewed as tools rather than shortcuts